Pfizer Inc. Soars on Positive Phase 3 Trial Results for PADCEV
PFE stock surged following positive results from the Phase 3 EV-304 trial for PADCEV. Here's why this news is significant for investors.
Yahoo Finance · 4 min read
PFE Pfizer Inc.
Healthcare
Pharmaceuticals
Latest news and analysis for Pfizer Inc. (PFE).
Current Price
$27.26
-0.39
(-1.41%)
Market data may be delayed
Price Chart
Loading chart...
All Articles for PFE
Yahoo Finance · 4 min read
Pfizer Inc. Advances on Robust Pipeline Insights
PFE showcases a robust pipeline essential for its growth strategy, raising investor confidence. How will this impact Pfizer Inc.'s stock performance?
Yahoo Finance · 4 min read
PFE Momentum Builds on Strong 6.7% Monthly Returns
PFE shares have climbed 6.7% over the past month, drawing renewed investor interest. Discover the key insights behind this movement.
Yahoo Finance · 4 min read
Deep Dive: API Market Growth Reshapes Outlook for PFE
PFE stands to benefit from the API market's projected growth to USD 198.39 billion by 2030, driven by oncology and diabetes advancements.
Yahoo Finance · 4 min read